InMed Pharmaceuticals GAAP EPS of -$3.64, revenue of $1.11M
Source: SeekingAlpha
2025-02-13 02:33:43 ET
More on InMed Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
InMed Pharmaceuticals GAAP EPS of -$3.64, revenue of $1.11M
InMed Pharmaceuticals Inc.
NASDAQ: INM
INM Trading
123.81% G/L:
$1.555 Last:
73,877,530 Volume:
$1.79 Open:
